Home  »  Industry   »  A Tale of Resilience: Outlook Therapeutics Inc. Am...

A Tale of Resilience: Outlook Therapeutics Inc. Amid Stock Market Turbulence

Currently, the stock price of Outlook Therapeutics Inc. (OTLK) is $0.21. In the most recent trading session, the stock underwent a significant upswing, peaking at $0.2211 after opening at $0.22. The stock touched a low of $0.2111 before closing at $0.21.

Outlook Therapeutics Inc.’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $2.03 on 06/06/23, and the lowest price during that time was $0.20, recorded on 09/08/23.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


52-week price history of OTLK Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Outlook Therapeutics Inc.’s current trading price is -89.55% away from its 52-week high, while its distance from the 52-week low is 5.94%. The stock’s price range during this period has fluctuated between $0.20 and $2.03. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.55 million for the day, which was evidently lower than the average daily volume of 5.58 million over the last three months.

Financial Performance and Market Capitalization

Outlook Therapeutics Inc. (OTLK) has experienced a quarterly decline of -88.02% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 58.40M and boasts a workforce of 17 employees.

Analysts’ Ratings For Outlook Therapeutics Inc.

As of right now, 1 analyst is rating Outlook Therapeutics Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3406, with a change in price of -0.8680. Similarly, Outlook Therapeutics Inc. recorded 3,983,902 in trading volume during the last 100 days, posting a change of -80.37%.

OTLK Stock Stochastic Average

The raw stochastic average for Outlook Therapeutics Inc. over the last 50 days is presently at 0.72%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 0.94%. Further, the company’s Stochastic %K and %D values for the last 20 days were 1.03% and 1.48%, respectively.

OTLK Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -80.36%. However, over the past six months, we’ve seen a stronger performance of -79.41%. The price of OTLK leaped by -84.05% over the last 30 days. And in the last five days, it has fallen by -2.48%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts